Literature DB >> 11036052

Resistance to multiple fluoroquinolones in a clinical isolate of Streptococcus pyogenes: identification of gyrA and parC and specification of point mutations associated with resistance.

S S Yan1, M L Fox, S M Holland, F Stock, V J Gill, D P Fedorko.   

Abstract

A strain of Streptococcus pyogenes resistant to multiple fluoroquinolones was isolated from the blood of an immunocompromised patient. Resistance to fluoroquinolones in S. pyogenes has not been previously studied. Compared to 10 sensitive strains of S. pyogenes, the fluoroquinolone-resistant clinical isolate of S. pyogenes presented point mutations in gyrA, predicting that serine-81 was changed to phenylalanine and that methionine-99 was changed to leucine, and in parC, predicting that serine-79 was changed to tyrosine. The mechanism of fluoroquinolone resistance in this isolate of S. pyogenes appears to be analogous to previously reported mechanisms for Streptococcus pneumoniae.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11036052      PMCID: PMC101632          DOI: 10.1128/AAC.44.11.3196-3198.2000

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  17 in total

Review 1.  Invasive group A streptococcus infections.

Authors:  D L Stevens
Journal:  Clin Infect Dis       Date:  1992-01       Impact factor: 9.079

2.  Molecular characterization of the gene encoding the DNA gyrase A subunit of Streptococcus pneumoniae.

Authors:  D Balas; E Fernández-Moreira; A G De La Campa
Journal:  J Bacteriol       Date:  1998-06       Impact factor: 3.490

Review 3.  Mechanism of fluoroquinolone action.

Authors:  K Drlica
Journal:  Curr Opin Microbiol       Date:  1999-10       Impact factor: 7.934

4.  Comparative in vitro activities of four new fluoroquinolones against Streptococcus pneumoniae determined by Etest.

Authors:  K Waites; E Brookings; S Nix; A Robinson; B Gray; E Swiatlo
Journal:  Int J Antimicrob Agents       Date:  1998-02       Impact factor: 5.283

5.  ParC subunit of DNA topoisomerase IV of Streptococcus pneumoniae is a primary target of fluoroquinolones and cooperates with DNA gyrase A subunit in forming resistance phenotype.

Authors:  R Muñoz; A G De La Campa
Journal:  Antimicrob Agents Chemother       Date:  1996-10       Impact factor: 5.191

6.  Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae.

Authors:  X S Pan; J Ambler; S Mehtar; L M Fisher
Journal:  Antimicrob Agents Chemother       Date:  1996-10       Impact factor: 5.191

7.  Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli.

Authors:  H Yoshida; M Bogaki; M Nakamura; S Nakamura
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

8.  Targeting of DNA gyrase in Streptococcus pneumoniae by sparfloxacin: selective targeting of gyrase or topoisomerase IV by quinolones.

Authors:  X S Pan; L M Fisher
Journal:  Antimicrob Agents Chemother       Date:  1997-02       Impact factor: 5.191

9.  Contribution of mutations in gyrA and parC genes to fluoroquinolone resistance of mutants of Streptococcus pneumoniae obtained in vivo and in vitro.

Authors:  J Tankovic; B Perichon; J Duval; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1996-11       Impact factor: 5.191

10.  High-level fluoroquinolone resistance in Streptococcus pneumoniae requires mutations in parC and gyrA.

Authors:  C Janoir; V Zeller; M D Kitzis; N J Moreau; L Gutmann
Journal:  Antimicrob Agents Chemother       Date:  1996-12       Impact factor: 5.191

View more
  23 in total

1.  parC mutation conferring ciprofloxacin resistance in Streptococcus pyogenes BM4513.

Authors:  Rodrigo Alonso; Marc Galimand; Patrice Courvalin
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

2.  Streptococcus pyogenes pharyngeal isolates with reduced susceptibility to ciprofloxacin in Spain: mechanisms of resistance and clonal diversity.

Authors:  Sebastián Albertí; Guadalupe Cortés; Cesar García-Rey; Carmen Rubio; Fernando Baquero; José Angel García-Rodríguez; Emilio Bouza; Lorenzo Aguilar
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

3.  Antimicrobial susceptibility survey of Streptococcus pyogenes isolated in Japan from patients with severe invasive group A streptococcal infections.

Authors:  Tadayoshi Ikebe; Kyoko Hirasawa; Rieko Suzuki; Junko Isobe; Daisuke Tanaka; Chihiro Katsukawa; Ryuji Kawahara; Masaaki Tomita; Kikuyo Ogata; Miyoko Endoh; Rumi Okuno; Haruo Watanabe
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

4.  Clonal spread of pediatric isolates of ciprofloxacin-resistant, emm type 6 Streptococcus pyogenes.

Authors:  Rodrigo Alonso; Estibaliz Mateo; Marc Galimand; Javier Garaizar; P Courvalin; Ramón Cisterna
Journal:  J Clin Microbiol       Date:  2005-05       Impact factor: 5.948

5.  Detection of Streptococcus pyogenes by use of Illumigene group A Streptococcus assay.

Authors:  Amanda M Henson; Donna Carter; Kathleen Todd; Stanford T Shulman; Xiaotian Zheng
Journal:  J Clin Microbiol       Date:  2013-09-18       Impact factor: 5.948

6.  Emergence of ciprofloxacin-nonsusceptible Streptococcus pyogenes isolates from healthy children and pediatric patients in Portugal.

Authors:  Renato Pires; Carmen Ardanuy; Dora Rolo; Ana Morais; António Brito-Avô; José Gonçalo-Marques; Josefina Liñares; Ilda Santos-Sanches
Journal:  Antimicrob Agents Chemother       Date:  2010-03-29       Impact factor: 5.191

7.  Novel conserved group A streptococcal proteins identified by the antigenome technology as vaccine candidates for a non-M protein-based vaccine.

Authors:  Andrea Fritzer; Beatrice M Senn; Duc Bui Minh; Markus Hanner; Dieter Gelbmann; Birgit Noiges; Tamás Henics; Kai Schulze; Carlos A Guzman; John Goodacre; Alexander von Gabain; Eszter Nagy; Andreas L Meinke
Journal:  Infect Immun       Date:  2010-07-12       Impact factor: 3.441

8.  Molecular characterization of acquired enrofloxacin resistance in Mycoplasma synoviae field isolates.

Authors:  I Lysnyansky; I Gerchman; I Mikula; F Gobbo; S Catania; S Levisohn
Journal:  Antimicrob Agents Chemother       Date:  2013-04-22       Impact factor: 5.191

9.  Emergence of fluoroquinolone resistance in group B streptococcal isolates in Taiwan.

Authors:  Hsiu-Mei Wu; Rajendra Prasad Janapatla; Yueh-Ren Ho; Kuei-Hsiang Hung; Chi-Wen Wu; Jing-Jou Yan; Jiunn-Jong Wu
Journal:  Antimicrob Agents Chemother       Date:  2008-02-25       Impact factor: 5.191

10.  First Streptococcus agalactiae isolates highly resistant to quinolones, with point mutations in gyrA and parC.

Authors:  Yoshiaki Kawamura; Hiromitsu Fujiwara; Noriko Mishima; Yuko Tanaka; Ayako Tanimoto; Shiro Ikawa; Youko Itoh; Takayuki Ezaki
Journal:  Antimicrob Agents Chemother       Date:  2003-11       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.